急性胰腺炎(AP)是消化内科的多发病、常见病,其预后较差,并发症多,病情变化快~([1])。AP的发展发生过程中,炎症细胞因子占很重要的地位~([2])。目前临床常用的治疗AP的药物是生长抑素,具有抑制炎症级联反应,保护胰腺黏膜细胞,抑制胰液分泌等作用~([3])。乌司他丁是一种广谱胰酶抑制剂。本研究观察AP患者采用生长抑素 Acute pancreatitis (AP) is a frequently-occurring disease and common disease of digestive medicine, with poor prognosis, multiple complications and rapid changes of the disease (1). During the development of AP, inflammatory cytokines occupy an important position ~ ([2]). At present, commonly used drugs for the treatment of AP are somatostatin, which can inhibit the inflammatory cascade, protect the pancreatic mucosal cells and inhibit the secretion of pancreatic juice. (3) Ulinastatin is a broad-spectrum trypsin inhibitor. This study observed AP patients with somatostatin